A detailed history of Two Sigma Investments, LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 19,413 shares of OCUL stock, worth $132,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,413
Previous 111,000 82.51%
Holding current value
$132,784
Previous $495,000 64.44%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$3.85 - $10.93 $352,609 - $1 Million
-91,587 Reduced 82.51%
19,413 $176,000
Q4 2023

Feb 14, 2024

SELL
$2.08 - $4.52 $10,608 - $23,051
-5,100 Reduced 4.39%
111,000 $495,000
Q3 2023

Nov 14, 2023

SELL
$3.14 - $5.04 $63,428 - $101,808
-20,200 Reduced 14.82%
116,100 $364,000
Q2 2023

Aug 14, 2023

SELL
$4.6 - $7.64 $860,770 - $1.43 Million
-187,124 Reduced 57.86%
136,300 $703,000
Q1 2023

May 15, 2023

BUY
$2.79 - $6.27 $374,805 - $842,305
134,339 Added 71.05%
323,424 $1.7 Million
Q4 2022

Feb 14, 2023

SELL
$2.61 - $4.41 $22,641 - $38,256
-8,675 Reduced 4.39%
189,085 $531,000
Q3 2022

Nov 14, 2022

BUY
$4.09 - $6.5 $808,838 - $1.29 Million
197,760 New
197,760 $821,000
Q2 2022

Aug 15, 2022

SELL
$3.01 - $5.22 $1.45 Million - $2.52 Million
-483,284 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$4.83 - $7.35 $64,808 - $98,622
13,418 Added 2.86%
483,284 $2.39 Million
Q4 2021

Feb 14, 2022

SELL
$6.16 - $12.07 $2.62 Million - $5.14 Million
-425,534 Reduced 47.52%
469,866 $3.28 Million
Q3 2021

Nov 15, 2021

SELL
$9.7 - $14.34 $1.36 Million - $2.02 Million
-140,645 Reduced 13.58%
895,400 $8.95 Million
Q2 2021

Aug 16, 2021

SELL
$13.43 - $19.16 $1.78 Million - $2.54 Million
-132,413 Reduced 11.33%
1,036,045 $14.7 Million
Q1 2021

May 17, 2021

BUY
$15.82 - $22.11 $3.93 Million - $5.49 Million
248,163 Added 26.97%
1,168,458 $19.2 Million
Q4 2020

Feb 16, 2021

BUY
$7.91 - $22.95 $4.67 Million - $13.5 Million
589,995 Added 178.62%
920,295 $19.1 Million
Q3 2020

Nov 16, 2020

BUY
$7.36 - $9.87 $1.04 Million - $1.4 Million
141,385 Added 74.84%
330,300 $2.51 Million
Q2 2020

Aug 14, 2020

BUY
$4.67 - $8.95 $768,467 - $1.47 Million
164,554 Added 675.48%
188,915 $1.57 Million
Q1 2020

May 15, 2020

BUY
$3.95 - $7.4 $96,225 - $180,271
24,361 New
24,361 $121,000
Q2 2019

Aug 14, 2019

SELL
$2.46 - $4.52 $75,613 - $138,931
-30,737 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$3.51 - $4.77 $138,448 - $188,147
-39,444 Reduced 56.2%
30,737 $122,000
Q4 2018

Feb 14, 2019

BUY
$3.87 - $7.11 $198,089 - $363,932
51,186 Added 269.47%
70,181 $279,000
Q3 2018

Nov 14, 2018

BUY
$5.42 - $6.99 $102,952 - $132,775
18,995 New
18,995 $131,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $526M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.